0001104659-23-083066.txt : 20230721
0001104659-23-083066.hdr.sgml : 20230721
20230721163015
ACCESSION NUMBER: 0001104659-23-083066
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230721
DATE AS OF CHANGE: 20230721
EFFECTIVENESS DATE: 20230721
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851410058
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-487617
FILM NUMBER: 231102831
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 973-242-0005
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
D
1
primary_doc.xml
X0708
D
LIVE
0001815903
Petros Pharmaceuticals, Inc.
1185 AVENUE OF THE AMERICAS
3RD FLOOR
NEW YORK
NY
NEW YORK
10036
973-242-0005
DELAWARE
None
None
Corporation
true
2020
Mitchell
Arnold
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Executive Officer
Vice President of Finance and Principal Accounting Officer
Fady
Boctor
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Executive Officer
President and Chief Commercial Officer
John
D.
Shulman
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Director
Joshua
N.
Silverman
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Director
Bruce
T.
Bernstein
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Director
Gregory
Bradley
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Director
Wayne
R.
Walker
1185 Avenue of the Americas
3rd Floor
New York
NY
NEW YORK
10036
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-07-13
false
true
true
true
false
0
Katalyst Securities LLC
112494
None
None
655 THIRD AVENUE, 18TH FLOOR
NEW YORK
NY
NEW YORK
10017
CT
CONNECTICUT
FL
FLORIDA
NJ
NEW JERSEY
NY
NEW YORK
false
30000006
30000006
0
Includes aggregate exercise price of warrants of $2.25 (subject to price-based adjustment), that may be received upon exercise of the warrants
false
15
1200000
0
Issuer issued to placement agent (and its designees) warrants to purchase up to 533,334 shares at an exercise price of $2.25 (subject to price-based adjustment) under Section 4(a)(2)
0
false
Petros Pharmaceuticals, Inc.
/s/ Fady Boctor
Fady Boctor
President and Chief Commercial Officer
2023-07-21